Literature DB >> 29090639

Platelet-rich concentrate in serum-free medium enhances cartilage-specific extracellular matrix synthesis and reduces chondrocyte hypertrophy of human mesenchymal stromal cells encapsulated in alginate.

Shani Samuel1,2, Raja Elina Ahmad1, Thamil Selvee Ramasamy3, Puvanan Karunanithi2, Sangeetha Vasudevaraj Naveen2, Tunku Kamarul2.   

Abstract

Platelet-rich concentrate (PRC), used in conjunction with other chondroinductive growth factors, have been shown to induce chondrogenesis of human mesenchymal stromal cells (hMSC) in pellet culture. However, pellet culture systems promote cell hypertrophy and the presence of other chondroinductive growth factors in the culture media used in previous studies obscures accurate determination of the effect of platelet itself in inducing chondrogenic differentiation. Hence, this study aimed to investigate the effect of PRC alone in enhancing the chondrogenic differentiation potential of human mesenchymal stromal cells (hMSC) encapsulated in three-dimensional alginate constructs. Cells encapsulated in alginate were cultured in serum-free medium supplemented with only 15% PRC. Scanning electron microscopy was used to determine the cell morphology. Chondrogenic molecular signature of hMSCs was determined by quantitative real-time PCR and verified at protein levels via immunohistochemistry and enzyme-linked immunosorbent assay. Results showed that the cells cultured in the presence of PRC for 24 days maintained a chondrocytic phenotype and demonstrated minimal upregulation of cartilaginous extracellular matrix (ECM) marker genes (SOX9, TNC, COL2, ACAN, COMP) and reduced expression of chondrocyte hypertrophy genes (Col X, Runx2) compared to the standard chondrogenic medium (p < 0.05). PRC group had correspondingly higher levels of glycosaminoglycan and increased concentration of chondrogenic specific proteins (COL2, ACAN, COMP) in the ECM. In conclusion, PRC alone appears to be very potent in inducing chondrogenic differentiation of hMSCs and offers additional benefit of suppressing chondrocyte hypertrophy, rendering it a promising approach for providing abundant pool of chondrogenic MSCs for application in cartilage tissue engineering.

Entities:  

Keywords:  Blood; cartilage repair; chondrogenesis; extra-cellular matrix; regenerative medicine; stem cells; tissue engineering

Mesh:

Substances:

Year:  2017        PMID: 29090639     DOI: 10.1080/09537104.2017.1371287

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  6 in total

1.  Co-cultured Bone-marrow Derived and Tendon Stem Cells: Novel Seed Cells for Bone Regeneration.

Authors:  Yang Liu; Chengsong Yuan; Mei Zhou; Kanglai Tang
Journal:  Open Life Sci       Date:  2019-12-31       Impact factor: 0.938

2.  Betulinic acid decreases lipid accumulation in adipogenesis-induced human mesenchymal stem cells with upregulation of PGC-1α and UCP-1 and post-transcriptional downregulation of adiponectin and leptin secretion.

Authors:  Sasithon Senamontree; Thitiporn Lakthan; Pornsri Charoenpanich; Chanpen Chanchao; Adisri Charoenpanich
Journal:  PeerJ       Date:  2021-10-14       Impact factor: 2.984

Review 3.  Application of Alginate Hydrogels for Next-Generation Articular Cartilage Regeneration.

Authors:  Wei Liu; Henning Madry; Magali Cucchiarini
Journal:  Int J Mol Sci       Date:  2022-01-20       Impact factor: 5.923

Review 4.  Progress of Platelet Derivatives for Cartilage Tissue Engineering.

Authors:  Siyu Wu; Wenlai Guo; Rui Li; Xi Zhang; Wenrui Qu
Journal:  Front Bioeng Biotechnol       Date:  2022-06-16

5.  Synthesis and Evaluation of AlgNa-g-Poly(QCL-co-HEMA) Hydrogels as Platform for Chondrocyte Proliferation and Controlled Release of Betamethasone.

Authors:  Jomarien García-Couce; Marioly Vernhes; Nancy Bada; Lissette Agüero; Oscar Valdés; José Alvarez-Barreto; Gastón Fuentes; Amisel Almirall; Luis J Cruz
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

Review 6.  Chondrocyte Aging: The Molecular Determinants and Therapeutic Opportunities.

Authors:  Thamil Selvee Ramasamy; Yong Mei Yee; Ilyas M Khan
Journal:  Front Cell Dev Biol       Date:  2021-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.